2nd Oxford Global Annual Peptides Congress 2015 London

  • Conference Call
  • Oxford Global Conferences Ltd are proud to announce the 2nd Annual Peptides Congress, taking place on 20 – 21 April 2015 in London, United Kingdom at the Novotel London West.

    The conference provides an exclusive opportunity for over 350 experts working in different areas of the peptides industry to exchange their experiences, engage in scientific discussions and network with senior-​level attendees about the most pressing challenges of the industry.

    Peptides qualify to be used for various therapeutic solutions to address the growing horizons of medical challenges. It is estimated that the global peptide therapeutics market will reach $25 billion by 2018. Thanks to the opportunities novel technologies, applications and numerous studies focusing on peptides offer, the industry is flourishing more than ever.

    The 2nd Annual Peptides Congress forms part of Oxford Global’s highly successful Biologics Series and is co-​located with the 8th Annual Proteins & Antibodies Congress and the 3rd Annual Biosimilars & Biobetters Congress.


    In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 20 speakers will present a full conference programme covering the topics outlined below. These topics have been compiled as a result of a comprehensive research process undertaken with our advisory board members including VPs, Directors, Senior Research Fellows and Professors from global pharmaceutical organisations and leading research institutions.

    Day 1 – Enabling Technologies For Peptide Screening, Synthesis And Modification

    Day one will explore enabling technologies for peptide screening, synthesis and modification. Internationally renowned leaders will address new approaches for high-​throughput screening, novel peptide conjugation strategies to enhance potency and half-​life and activating different synthesis technologies. Presentations will explore the future opportunities in peptide design and creating diversity within peptide libraries.

    • Promising methods to extend half-​life peptide capabilities
    • Activating synthesis technologies: HLPC, mass spectrometry, microwave-​assisted SPPS
    • Enhancing peptide stability through PEGylation, cyclization and amino acid incorporation
    • Updates in peptide self-​assembly & macromolecular assembly
    • Advances in research involving high affinity binding peptides
    • Novel peptide applications for intracellular targets
    • New approaches for high-​throughput screening

    Day 2 – Peptide Case Studies

    Day two of the congress will focus on peptide case studies covering discovery, preclinical and clinical development, therapeutic applications, peptide formulation and delivery. Esteemed experts will deliver presentations on enhancing the oral bioavailability and drugability of peptides, updates in discovery and preclinical and clinical development. Delegates will also have the opportunity to learn about recent developments involving cell-​penetrating peptides, macrocyclic, polypeptides and bioactive peptides.

    • Updates in preclinical discovery and clinical development
    • Innovative therapeutic applications for peptides
    • Latest advances and future perspectives in peptide delivery
    • Cell-​penetrating peptides: opportunities, challenges and future directions
    • New strategies utilizing routes of administration for peptide formulation
    • Peptidomimetics: enhancing drugability and bioavailability
    • Recent developments: macrocyclic, polypeptides and bioactive peptides

    Confirmed speakers for 2015

    • Konrad Bleicher
      Peptide Area Head Discovery Chemistry, pRED, Roche Innovation Centre Basel
    • Christophe Bonny
      Chief Scientific Officer, Bicycle Therapeutics Ltd
    • David Edmonds
      Principal Scientist, Pfizer
    • Fabio Fais
      Principal Scientist, Novartis
    • Paul Feldman
      Senior Vice President, EE DPU, RD Metabolic Pathways & Cardio Unit, GSK
    • Torsten Hoffmann
      Executive Vice President and Chief Scientific Officer, Zealand Pharma
    • Lutz Jermutus
      Senior Director, R&D, MedImmune
    • Lyn Jones
      Head of Rare Diseases Chemistry, Head of Chemical Biology, Pfizer
    • Aphrodite Kapurniotu
      Professor, Division of Peptide Biochemistry, TU München
    • Daniel Kirchhofer
      Principal Scientist, Early Discovery Biochemistry, Genentech
    • Tomas Landh
      Director, Strategy and Innovation Sourcing Diabetes Research Unit, Novo Nordisk
    • Alastair Lawson
      Research Fellow & VP Structural Biology, UCB
    • Alireza Manuchehri
      Director, Clinical Development, Eisai Ltd
    • Gert Moll
      CSO, Lanthio Pharma
    • Dinesh Patel
      President & CEO, Protagonist Therapeutics
    • Joel Richard
      Joel Richard, Senior Vice President, Peptides – Head of CMCS Dreux Site, Ipsen
    • Graham Simpson
      CPU Head, Peptides Chemistry, GlaxoSmithKline
    • Michael Wagner
      Head of Peptides, Sanofi-​Aventis
    • Daniel Yin
      Principal Scientist, Parenteral Formulation Sciences, Merck

    Submit a poster

    For attendees interested in submitting a poster, there are opportunities now available. Your poster presentation will be located in the exhibition room for two days alongside other posters from senior scientists working in industry and academia.

    How to submit your abstract

    We will require:

    • Poster title, Abstract (200 words or less)
    • Principal author, Organisation, Mailing address
    • Email, Telephone, Fax
    • Additional authors

    In order to secure your board space a fee of £250 plus VAT will be required. The poster should be presented as A0 (841mm x 1189mm) portrait size.

    To take advantage of this opportunity you need to be registered as a paid delegate over the 2 days. We have limited spaces available so please register soon!

    Who will attend

    The 2nd Annual Peptides Congress is an exclusive event consisting of world-​class keynote addresses and panel discussions designed specifically for senior level attendees from leading pharmaceutical and biopharmaceutical, biotechnology, diagnostics, academics, government, CRO and solution provider companies. Delegates typically include VPs, Directors, Managers and Heads of:

    • Biologics Drug Discovery
    • Biologics Research
    • Biotherapeutics Research
    • Discovery Chemistry
    • Discovery Technologies
    • Medicinal Chemistry
    • Molecular Biology
    • Peptide and Protein Chemistry
    • Peptide Characterisation
    • Peptide Delivery
    • Peptide Development
    • Peptide Discovery
    • Peptide Engineering
    • Peptide Formulation
    • Peptide Optimisation
    • Peptide Synthesis
    • Peptidomimetics
    • R&D Technologies
    • Technology Innovation
    • Therapeutic Peptides
    starting: ending: 21.04.2015 Location: , Category:


    Conference START 21.04.2015 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Novotel London West, Shortlands 1 Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.